Trending News
News
News
No European Patent for WARF/Thomson Stem Cell Application
The Enlarged Board of Appeal (EBoA) of the EPO has made a ruling which prohibits the patenting of human stem cell cultures whose preparation necessarily involves the destruction of human embryos.
News
Scientists Achieve Robust Repair of Injured Heart Muscle in Laboratory Tests of Novel Stem Cells
Researchers at Children’s Hospital of Pittsburgh effectively repaired damaged heart muscle in an animal model using stem cells.
News
GENEART Receives Major Contract from the Wellcome Trust Sanger Institute
The Wellcome Trust awards a major contract on synthesizing up to 600 genes over the next 10 months to GENEART.
News
MorphoSys and Galapagos Enter Alliance to Co-develop Therapeutic Antibodies in Bone and Joint Disease
The alliance combines proprietary drug targets and technologies to create range of new therapeutic antibodies.
News
Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication
Cephalon obtains an exclusive, worldwide license to the investigational medication Lupuzor™ for the treatment of Systemic Lupus Erythematosus.
News
Harvard Medical School and Cellectricon collaborates Around Whole-Genome RNAi Screening Technology
Harvard Medical School will utilize the Cellaxess®HT system for high throughput transfection enabling reagent-free delivery of genetic material.
News
New Applications Data Demonstrates High Quality Peptide Synthesis
Activotec announce new applications data that demonstrates the Activo-P11 Peptide Synthesizer as a choice for a growing number of laboratories worldwide.
News
Proxeon Partners in the EU-funded PROSPECTS Research Consortium
Leading institutes and suppliers collaborate on development of next-generation proteomic technologies.
News
Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals
Roche to acquire all the outstanding shares of Memory Pharmaceuticals for approximately USD 50 million.
News
UT Southwestern Researchers Find Clue to Safer Obesity Drugs
Scientists are trying to understand how a miracle weight-loss drug behaves in the brain in order to develop safer anti-obesity drugs with fewer side effects.
Advertisement